Warwick, Alasdair N.
Curran, Katie
Hamill, Barbra
Stuart, Kelsey https://orcid.org/0000-0001-7353-8774
Khawaja, Anthony P. https://orcid.org/0000-0001-6802-8585
Foster, Paul J. https://orcid.org/0000-0002-4755-177X
Lotery, Andrew J. https://orcid.org/0000-0001-5541-4305
Quinn, Michael
Madhusudhan, Savita
Balaskas, Konstantinos
Peto, Tunde https://orcid.org/0000-0001-6265-0381
,
Allen, N.
Aslam, T.
Atan, D.
Barman, S.
Barrett, J.
Bishop, P.
Black, G.
Braithwaite, T.
Carare, R.
Chakravarthy, U.
Chan, M.
Chua, S.
Day, A.
Desai, P.
Dhillon, B.
Dick, A.
Doney, A.
Egan, C.
Ennis, S.
Foster, P.
Fruttiger, M.
Gallacher, J.
Garway-Heath, D.
Gibson, J.
Guggenheim, J.
Hammond, C.
Hardcastle, A.
Harding, S.
Hogg, R.
Hysi, P.
Keane, P.
Khaw, P. T.
Khawaja, A.
Lascaratos, G.
Littlejohns, T.
Lotery, A.
Luthert, P.
Macgillivray, T.
Mackie, S.
Mcguinness, B.
Mckay, G.
Mckibbin, M.
Moore, T.
Morgan, J.
Oram, R.
O’sullivan, E.
Owen, C.
Patel, P.
Paterson, E.
Peto, T.
Petzold, A.
Pontikos, N.
Rahi, J.
Rudnicka, A.
Sattar, N.
Self, J.
Sergouniotis, P.
Sivaprasad, S.
Steel, D.
Stratton, I.
Strouthidis, N.
Sudlow, C.
Sun, Z.
Tapp, R.
Thomas, D.
Trucco, E.
Tufail, A.
Viswanathan, A.
Vitart, V.
Weedon, M.
Williams, K.
Williams, C.
Woodside, J.
Yates, M.
Yip, J.
Zheng, Y.
Funding for this research was provided by:
Fight for Sight UK (1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508, 1507 & 1508)
Moorfields Eye Charity (Previous Moorfields Special Trustees ref: ST 15 11 E) The Macular Society (London) - No award/grant number
Article History
Received: 14 May 2022
Revised: 26 September 2022
Accepted: 18 October 2022
First Online: 3 November 2022
Change Date: 5 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41433-022-02377-9
Competing interests
: ANW, KC, BH, KS, AJL, PJF, MQ and SM declare no competing interests. AC’s financial interests: Consultant/Contractor (Aerie, Google Health, Novartis, Reichert, Santen, Thea, Abbvie). KB’s financial interests: Consultant/Contractor (Roche, Novartis); Financial support (Roche, Novartis, Bayer, Apellis); Recipient: (Novartis, Bayer, Roche, Alimera, Heidelberg Engineering). TP’s financial interests: Consultant/Contractor (Optos and Optomed); Recipient (Allergan, Genentech/Roche, Oxurion, Novartis, Bayer, Heidelberg, Optos, Apellis, Alimera, Bayer). APK has acted as a consultant to Abbvie, Aerie, Google Health, Novartis, Reichert, Santen and Thea.